Tempest Therapeutics TPST
NASDAQ TPST
$0.52 0.00 (-0.82%)
At close: Oct 22, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) EV to CFO (2018)

Updated

Tempest Therapeutics' (TPST) EV to CFO stood at 43.52 in Q3 2018.

Analysis

Tempest Therapeutics (TPST) EV to CFO (2018) Analysis & Trends

On a TTM basis, Tempest Therapeutics' EV to CFO came in at -20.71 as of Sep 30, 2018.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Tempest Therapeutics 7.98 Mn -22.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 43.52
API Access

Tempest Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TPST&period=max&api_key=YOUR_API_KEY